Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer
View/ Open
Volume
34
Pagination
1987 - +
DOI
10.1200/JCO.2015.63.9179
Journal
JOURNAL OF CLINICAL ONCOLOGY
Issue
ISSN
0732-183X